…
Xybion Digital Inc., a software-as-a-service company, provides software solutions for life sciences and health systems companies in the United States and internationally. Its software solutions include Pristima XD, an integrated digital laboratory execution system; Labwise XD, a laboratory operations software to manage GMP and non-GMP-compliant process flows; and digital pathology software solutions. The company also provides COVID-19 test management application; Savante, a data warehouse, analytics, and SEND management system; QMS suite, an end-to-end unified cloud platforms for research and development, laboratory information management systems, and workplace health and safety; Compliance Risk Predictor to predict compliance risks, mitigate, and eliminate; and Compliance Builder, a real-time compliance monitoring software. In addition, it offers Emidence XD, a total workforce health and safety solution; and ECM XD, a cloud-based digital platform for managing enterprise content. Further, the company provides project management, computer system validation, and software development and testing services. It serves clients in life sciences, workplace health, safety and worker's compensation, transportation, energy, financial services, enterprise solutions, healthcare and insurance, and government industries. The company is headquartered in Princeton, New Jersey. Xybion Digital Inc. is a subsidiary of Banerjee Group LLC.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Income before tax | -0.32M | -1.75M | -0.56M | 2.79M | 1.80M |
| Net income | -0.31M | -1.33M | -0.98M | 2.28M | 1.39M |
| Selling general administrative | 8.46M | 8.85M | 6.98M | 5.59M | 5.99M |
| Gross profit | 11.12M | 10.38M | 11.15M | 9.41M | 9.52M |
| Reconciled depreciation | 0.46M | 0.46M | 0.46M | 0.46M | 0.47M |
| Ebit | - | -1.67M | 1.80M | 1.79M | 1.86M |
| Ebitda | - | - | -0.08M | 3.26M | 2.28M |
| Operating income | -0.25M | -1.67M | 1.98M | 1.89M | 1.86M |
| Other operating expenses | - | 0.64M | 0.45M | 0.29M | 0.48M |
| Interest expense | - | 0.01M | 0.02M | 0.01M | 0.02M |
| Tax provision | -0.01M | -0.42M | 0.42M | 0.51M | 0.41M |
| Net interest income | -0.03M | -0.05M | -0.02M | -0.01M | -0.02M |
| Income tax expense | - | -0.42M | 0.42M | 0.51M | 0.41M |
| Total revenue | 16.85M | 16.44M | 16.77M | 14.32M | 15.14M |
| Total operating expenses | 17.11M | 18.11M | 14.79M | 12.43M | 13.28M |
| Cost of revenue | 5.74M | 6.05M | 5.62M | 4.91M | 5.62M |
| Total other income expense net | -0.03M | -0.02M | -2.52M | 0.92M | -0.05M |
| Net income from continuing ops | -0.31M | -1.33M | -0.98M | 2.28M | 1.39M |
| Net income applicable to common shares | - | -1.33M | -0.98M | 2.28M | 1.39M |
| Breakdown | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 |
| Total assets | 16.56M | 17.48M | 16.14M | 12.89M | 11.65M |
| Other current assets | 0.12M | - | 0.03M | - | - |
| Total liab | 8.71M | 8.15M | 8.13M | 6.48M | 6.04M |
| Total stockholder equity | 7.85M | 9.32M | 8.02M | 6.41M | 5.61M |
| Deferred long term liab | 0.17M | - | 0.01M | - | - |
| Other current liab | 6.99M | 6.79M | 6.30M | 5.23M | 4.60M |
| Common stock | 5.56M | 5.55M | 2.48M | 0.15M | 0.15M |
| Capital stock | 5.56M | 5.55M | 0.15M | 0.15M | 0.15M |
| Retained earnings | 2.20M | 3.53M | 5.26M | 3.73M | 2.95M |
| Good will | 2.30M | 2.31M | 2.31M | 2.29M | 2.30M |
| Other assets | 0.85M | 0.23M | 0.50M | 0.58M | 0.66M |
| Cash | 5.29M | 8.15M | 6.46M | 4.12M | 3.41M |
| Total current liabilities | 8.16M | 7.71M | 7.46M | 6.29M | 5.70M |
| Other stockholder equity | -0.29M | -0.10M | -0.01M | -0.06M | 0.02M |
| Property plant equipment | 1.09M | 0.96M | 1.36M | 0.77M | 0.78M |
| Total current assets | 12.32M | 13.97M | 11.97M | 9.24M | 7.90M |
| Net tangible assets | 5.55M | 7.01M | 5.70M | 4.11M | 3.31M |
| Net receivables | 6.40M | 5.13M | 5.12M | 4.82M | 4.14M |
| Accounts payable | 0.41M | 0.34M | 0.41M | 0.33M | 0.45M |
| Non current assets total | 4.24M | 3.50M | 4.17M | 3.65M | 3.74M |
| Capital lease obligations | 0.90M | 0.67M | 1.02M | 0.51M | 0.62M |
| Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Investments | -0.02M | -0.02M | 0.71M | -0.24M | -0.26M |
| Change to liabilities | - | 0.62M | 0.41M | 1.05M | 0.64M |
| Total cashflows from investing activities | - | -0.02M | 0.71M | -0.24M | -0.26M |
| Net borrowings | - | -0.34M | -0.35M | 0.75M | -0.31M |
| Total cash from financing activities | -0.37M | -0.55M | -0.07M | 0.00M | -0.91M |
| Change to operating activities | - | 0.03M | -0.38M | -0.07M | -0.00M |
| Net income | 1.25M | -1.33M | -0.37M | 2.28M | 1.39M |
| Change in cash | 1.41M | -2.86M | 1.69M | 2.34M | 0.72M |
| Begin period cash flow | 5.42M | 8.15M | 6.46M | 4.12M | 3.41M |
| End period cash flow | 6.93M | 5.29M | 8.15M | 6.46M | 4.12M |
| Total cash from operating activities | 1.89M | -2.12M | 1.15M | 2.54M | 1.96M |
| Issuance of capital stock | 0.01M | 0.00M | 1.78M | 0.00M | - |
| Depreciation | 0.49M | 0.46M | 0.46M | 0.46M | 0.47M |
| Dividends paid | 0.00M | 0.00M | 0.75M | 0.75M | 0.60M |
| Change to account receivables | -0.94M | -1.23M | 0.07M | -0.35M | -0.62M |
| Other cashflows from financing activities | - | -0.21M | -0.75M | -0.75M | -0.75M |
| Change to netincome | - | -0.42M | 1.60M | -0.91M | 0.17M |
| Capital expenditures | 0.02M | 0.02M | 0.07M | 0.24M | 0.26M |
| Change in working capital | -0.31M | -0.87M | 0.06M | 0.72M | -0.06M |
| Stock based compensation | 0.04M | 0.03M | 0.03M | 0.03M | 0.09M |
| Other non cash items | 0.07M | 0.04M | 1.30M | - | - |
| Free cash flow | 1.88M | -2.14M | 1.08M | 2.31M | 1.70M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| NURS Hydreight Technologies Inc |
-0.04 1.32% |
2.98 | 406.00 | 25.91 | 7.85 | 20.38 | 7.45 | 109.02 |
| ADK Diagnos Inc |
-0.01 1.41% |
0.35 | - | 10.00 | 411.24 | 18.74 | 389.06 | -6.16 |
| NXG NexgenRX Inc. |
- -% |
0.66 | 39.00 | 32.68 | 1.55 | 4.64 | 1.39 | 7.84 |
| PTEC Principal Technologies Inc |
- -% |
0.32 | - | - | 62.75 | 355.42 | 72.08 | -0.81 |
Xybion Digital Inc., a software-as-a-service company, provides software solutions for life sciences and health systems companies in the United States and internationally. Its software solutions include Pristima XD, an integrated digital laboratory execution system; Labwise XD, a laboratory operations software to manage GMP and non-GMP-compliant process flows; and digital pathology software solutions. The company also provides COVID-19 test management application; Savante, a data warehouse, analytics, and SEND management system; QMS suite, an end-to-end unified cloud platforms for research and development, laboratory information management systems, and workplace health and safety; Compliance Risk Predictor to predict compliance risks, mitigate, and eliminate; and Compliance Builder, a real-time compliance monitoring software. In addition, it offers Emidence XD, a total workforce health and safety solution; and ECM XD, a cloud-based digital platform for managing enterprise content. Further, the company provides project management, computer system validation, and software development and testing services. It serves clients in life sciences, workplace health, safety and worker's compensation, transportation, energy, financial services, enterprise solutions, healthcare and insurance, and government industries. The company is headquartered in Princeton, New Jersey. Xybion Digital Inc. is a subsidiary of Banerjee Group LLC.
| Name | Title | Year Born |
|---|---|---|
| Dr. Pradip K. Banerjee M.B.A., Ph.D. | Founder, CEO & Chairman | NA |
| Mr. Kamal Biswas | Pres & COO | NA |
| Mr. Steven L. Porfano | CFO, Corp. Sec. & Exec. VP | NA |
| Mr. Mustafa Abdallah | Exec. Director of Quality & Compliance Services | NA |
| Mr. Bob Friedman | Chief Solution Architect | NA |
| Ms. Priya Rajesh | Head of Sales - APAC & EMEA | NA |
| Mr. Shawn Rabenstein | Head of IT | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.